Evidence map›Paper›PMID 35979992›Full record

ArticleActa obstetricia et gynecologica Scandinavica2022

Preoperative PET/CT score can predict incomplete resection after debulking surgery for advanced serous ovarian cancer better than CT score, MTV, tumor markers and hematological markers.

Jie Wang, Li Liu, Hua Pang, Lili Liu, Xingguo Jing, Yongmei Li

Registry-linked trialOpen access · diamondAbstract read
In one paragraph

Article in Acta obstetricia et gynecologica Scandinavica, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06533709 (Satisfactory Debulking Prediction Model for Advanced Ovarian Cancer Based on PET-CT Image Data and Its Clinical Application), which is not on this map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06533709 unknown statusnot on this mapstarted 2024, after this paper: background citation

Satisfactory Debulking Prediction Model for Advanced Ovarian Cancer Based on PET-CT Image Data and Its Clinical Application

TypeobservationalSponsorSun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRan2024 to 2026Enrolled146ConditionsOvarian Cancer, Image, PredationArmsRadio-score
3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: ASCO Guideline Update.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2025
    Guideline
  2. Article
  3. Article
  4. Article
  5. Predicting Complete Cytoreduction with Preoperative [Diagnostics (Basel, Switzerland) · 2024
    Review
  6. Article
  7. A comparative study of [European journal of nuclear medicine and molecular imaging · 2023
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Jie WangDepartment of Nuclear Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Li LiuDepartment of Radiology, The People's Hospital of Yubei District of Chongqing City, Chongqing, China.
Hua PangDepartment of Nuclear Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Lili LiuDepartment of Radiology, Chongqing General Hospital, University of Chinese Academy of Sciences, Chongqing, China.
Xingguo JingDepartment of Nuclear Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Yongmei LiDepartment of Radiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.ORCID 0000-0001-5558-9738
The Affiliated Yongchuan Hospital of Chongqing Medical University · CNUniversity of Chinese Academy of Sciences · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionComplete resection after debulking surgery is strongly associated with prolonged survival for advanced serous ovarian cancer (ASOC). Though positron emission tomography/computed tomography (PET/CT) is more advantageous than computed tomorgraphy (CT) for detecting metastases, studies on the PET/CT prediction model for incomplete resection for ovarian cancer are insufficient. We analyzed and compared the predictive value of preoperative PET/CT score, CT score, metabolic parameters, tumor markers and hematological markers for incomplete resection after debulking surgery for ASOC. MATERIAL AND

methodsA total of 62 ASOC patients who underwent preoperative [

resultsPreoperative PET/CT score had the highest predictive value for incomplete resection in primary debulking surgery group (sensitivity: 65.0%, specificity: 88.9%, area under the ROC curve (AUC): 0.847, p < 0.001), however, in secondary debulking surgery group, preoperative PET/CT score and CT score had the same and highest predictive value for incomplete resection (sensitivity: 80.0%, specificity: 94.7%, AUC: 0.853, p = 0.017), compared with preoperative metabolic parameters SUVmax and MTV, tumor markers HE4 and CA125, and hematological markers LMR, PLR and NLR. Preoperative PET/CT score ≥ 3 (Suidan model) and preoperative PET/CT score ≥ 2 predicted a high risk of incomplete resection after primary and secondary debulking surgeries, respectively. There was no statistical difference between primary and secondary debulking surgery groups in predictive value of PET/CT score for incomplete resection (p = 0.971). There were significant differences between PET/CT scores and CT scores in primary debulking surgery group and no significant differences in secondary debulking surgery group.

conclusionsA high PET/CT score predicted a high risk of incomplete resection. The preoperative PET/CT score had an identical predictive value in primary and secondary debulking surgery groups. PET/CT score was more accurate in the detection of metastases than CT score was.

Indexed as

Ovarian NeoplasmsPositron Emission Tomography Computed TomographyBiomarkers, TumorCA-125 AntigenCarcinoma, Ovarian EpithelialCytoreduction Surgical ProceduresFemaleFluorodeoxyglucose F18HumansPrognosisRadiopharmaceuticalsRetrospective StudiesTumor BurdenBiomarkers, TumorCA-125 AntigenFluorodeoxyglucose F18Radiopharmaceuticalsadvanced serous ovarian cancer, incomplete resectionpositron emission tomography/computed tomography score (PET/CT score)primary debulking surgerysecondary debulking surgerySuidan model

Identifiers

PMID35979992
PMCPMC9812200
OpenAlexW4293067380

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.